Atrimustine

ATN-161 trifluoroacetate salt is a novel integrin α5β1 antagonist, which inhibits angiogenesis and growth of liver metastases in a murine model.In VitroThe combination of ATN-161 plus 5-FU significantly reduces tumor cell proliferation compared to

ATN-161 trifluoroacetate salt is a novel integrin α5β1 antagonist, which inhibits angiogenesis and growth of liver metastases in a murine model.In VitroThe combination of ATN-161 plus 5-FU significantly reduces tumor cell proliferation compared to

ATN-161 trifluoroacetate salt is a novel integrin α5β1 antagonist, which inhibits angiogenesis and growth of liver metastases in a murine model.In VitroThe combination of ATN-161 plus 5-FU significantly reduces tumor cell proliferation compared to

ATN-161 trifluoroacetate salt is a novel integrin α5β1 antagonist, which inhibits angiogenesis and growth of liver metastases in a murine model.In VitroThe combination of ATN-161 plus 5-FU significantly reduces tumor cell proliferation compared to

ATN-161 trifluoroacetate salt is a novel integrin α5β1 antagonist, which inhibits angiogenesis and growth of liver metastases in a murine model.In VitroThe combination of ATN-161 plus 5-FU significantly reduces tumor cell proliferation compared to

ATR-IN-4 is a potent ATR (Ataxia telangiectasia mutated gene Rad 3-associated kinase) inhibitor. ATR-IN-4 inhibits growth of human prostate cancer cells DU145 and human lung cancer cells NCI-H460 with IC 50 s of 130.9 nM and 41.33 nM, respectively.

Atranorin is a lichen secondary metabolite. Atranorin inhibits lung cancer cell motility and tumorigenesis by affecting AP-1 , Wnt , and STAT signaling and suppressing RhoGTPase activityForm:SolidIC50&amp: Target:RhoGTPase.

Atranorin is a lichen secondary metabolite. Atranorin inhibits lung cancer cell motility and tumorigenesis by affecting AP-1 , Wnt , and STAT signaling and suppressing RhoGTPase activityForm:SolidIC50&amp: Target:RhoGTPase.

Atranorin is a lichen secondary metabolite. Atranorin inhibits lung cancer cell motility and tumorigenesis by affecting AP-1 , Wnt , and STAT signaling and suppressing RhoGTPase activityForm:SolidIC50&amp: Target:RhoGTPase.

Atranorin is a lichen secondary metabolite. Atranorin inhibits lung cancer cell motility and tumorigenesis by affecting AP-1 , Wnt , and STAT signaling and suppressing RhoGTPase activityIC50&amp: Target:RhoGTPase.

Atto 488 NHS ester is a hydrophilic fluorescent label with high water solubility. The fluorescence activity is excited efficiently at the 480-515nm range.

Application p -Anisaldehyde may be used as a triplet sensitizer to catalyze the photochemical intermolecular atom-transfer radical addition (ATRA) of haloalkanes onto olefins. It can be used to synthesize 2-(4-methoxybenzylidene)- N -(4-( N